Advertisement

Blastic plasmacytoid dendritic cell neoplasm with unusual lymphoid features and macrovacuoles

  • Kirill A. Lyapichev
  • Narittee Sukswai
  • Sergej Konoplev
  • Joseph D. KhouryEmail author
Letter to the Editor

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Research involving human participants and/or animals

This article does not contain any studies with human participants or animals performed by any of the authors.

References

  1. 1.
    Khoury JD (2018) Blastic plasmacytoid dendritic cell neoplasm. Curr Hematol Malig Rep 13(6):477–483.  https://doi.org/10.1007/s11899-018-0489-z CrossRefGoogle Scholar
  2. 2.
    Griffin JC, Aqel N, Siow W, Camilleri M, Ayto R (2017) Blastic plasmacytoid dendritic cell neoplasm: a pathological illustration of two clinical cases. Ann Hematol 96(10):1769–1770.  https://doi.org/10.1007/s00277-017-3079-6 CrossRefGoogle Scholar
  3. 3.
    Zheng G, Schmieg J, Guan H, Ali SZ (2012) Blastic plasmacytoid dendritic cell neoplasm: cytopathologic findings. Acta Cytol 56(2):204–208.  https://doi.org/10.1159/000332365 CrossRefGoogle Scholar
  4. 4.
    Wu HH, Ren R, Roepke JE (2004) Fine-needle aspiration cytology of blastic natural killer-cell lymphoma (CD4+ CD56+ hematodermic neoplasm). Diagn Cytopathol 30(4):268–270.  https://doi.org/10.1002/dc.20014 CrossRefGoogle Scholar
  5. 5.
    Ferreira J, Gasparinho MG, Fonseca R (2016) Cytomorphological features of blastic plasmacytoid dendritic cell neoplasm on FNA and cerebrospinal fluid cytology: a review of 6 cases. Cancer Cytopathol 124(3):196–202.  https://doi.org/10.1002/cncy.21645 CrossRefGoogle Scholar
  6. 6.
    Sakamoto K, Katayama R, Asaka R, Sakata S, Baba S, Nakasone H, Koike S, Tsuyama N, Dobashi A, Sasaki M, Ichinohasama R, Takakuwa E, Yamazaki R, Takizawa J, Maeda T, Narita M, Izutsu K, Kanda Y, Ohshima K, Takeuchi K (2018) Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response. Leukemia 32(12):2590–2603.  https://doi.org/10.1038/s41375-018-0154-5 CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Kirill A. Lyapichev
    • 1
  • Narittee Sukswai
    • 1
    • 2
  • Sergej Konoplev
    • 1
  • Joseph D. Khoury
    • 1
    Email author
  1. 1.Department of HematopathologyThe University of Texas MD Anderson Cancer CenterHoustonUSA
  2. 2.Department of PathologyChulalongkorn UniversityBangkokThailand

Personalised recommendations